- •The COVID-19 pandemic has generated a deleterious delay in the management of patients with aortic stenosis.
- •Ambulatory TAVR is safe in well selected patients.
- •A minimalist approach is mandatory to allow same-day discharge.
- Supplemental Table S1
- Supplemental Table S2
- Same day discharge after transcatheter aortic valve replacement: are we there yet?.Catheter Cardiovasc Interv. 2016; 87: 980-982
- A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.Catheter Cardiovasc Interv. 2020; 96: 459-470
- Temporal trends and clinical consequences of wait times for transcatheter aortic valve replacement: a population-based study.Circulation. 2018; 138: 483-493
- Triage considerations for patients referred for structural heart disease intervention during the coronavirus disease 2019 (COVID-19) pandemic: an ACC/SCAI consensus statement.Catheter Cardiovasc Interv. 2020; 13: 1607-1608
Durand E, Avinée G, Gillibert A, et al. Analysis of length of stay after transfemoral transcatheter aortic valve replacement: results from the FRANCE TAVI registry [e-pub ahead of print]. Clin Res Cardiol https://doi.org/10.1007/s00392-020-01647-4. Accessed September 22, 2020.
Ethics Statement: The research reported has adhered to the relevant ethical guidelines.
See page 731 for disclosure information.
User licenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) |
For non-commercial purposes:
- Read, print & download
- Redistribute or republish the final article
- Text & data mine
- Translate the article (private use only, not for distribution)
- Reuse portions or extracts from the article in other works
- Sell or re-use for commercial purposes
- Distribute translations or adaptations of the article
Elsevier's open access license policy